Patrick Gunning & Diana Kraskouskaya win the RBC Prize for Innovation and Entrepreneurship for Dalriada Therapeutics at the Entrepreneurship Week Startup Showcase 2017.
April 3, 2017
A novel therapeutic that has been shown in advanced pre-clinical studies to target cancer without the toxic side effects of treatments like chemotherapy has earned the Gunning Group the top prize in a new business pitch competition. Established to reward and accelerate U of T’s innovative technologies and start-ups, the RBC Prize for Innovation and Entrepreneurship was presented to Dalriada Therapeutics, a company co-founded by Professor Gunning. He and his team plan to use the $25,000 prize to further investigate the potential applications of the therapeutic, called DT1, on a range of cancers, including acute myeloid leukemia and glioblastoma, an aggressive, hard-to-treat cancer that begins within the brain.
Gunning Group at TEDxMississauga
December 15, 2015
Prof. Patrick Gunning is named the recipient of the CSC Bernard Belleau Award
November 23, 2015
Congrats Murtaza on Publishing the Tetris-based approach to targeting HDAC8